COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 09, 2020 |
Oct. 30, 2020 |
Jun. 30, 2016 |
Mar. 31, 2020 |
|
| Contingent sales fee description | A contingent sales fee upon product sales of 1% of sales or $150,000 whichever is greater. | |||
| Accrued fees | $ 150,000 | |||
| Accrued interest | 28,000 | |||
| Merger, description | Under the program, if an acquisition, merger or change in control is affected, 10% of the value of the transaction will be allocated to pay the expenses of the transaction including but not limited to legal, accounting, transfer fees and other miscellaneous expense. The balance of the fund after expenses will be allocation 20% to directors and 80% to officers and employees of the Company as allocated by the Chief Executive Officer and approved by the Board of Directors | |||
| Annual Maintenance | $ 178,000 | |||
| First BLA [Member] | ||||
| Future payments | $ 225,000 | |||
| First Phase III clinical trial [Member] | ||||
| Future payments | 225,000 | |||
| First Phase I clinical trial [Member] | ||||
| Future payments | 100,000 | |||
| Annual maintenance fee | $ 50,000 | |||
| Alpha Holding Inc [Member] | ||||
| Initial investment | $ 2,500,000 | |||
| Additional investment | 2,500,000 | |||
| Agreement from related party | $ 5,000,000 | |||
| Investment description | The investment will be in the Company’s common stock to be priced at a low of nine cents per share and a high of 10 cents per share subject to a 90 day weighted average pricing before closing. Upon completion of the $5,000,000 investment Alpha may elect a majority of the board of directors of the Company | |||